|
Wednesday, May 03, 2006
Results
with Newer Bladeless LASIK Equivalent to Standard Microkeratome
LASIK
|

LASIK SURGERY Ultrasound
probe measures the thickness of the cornea in preparation for
LASIK surgery at the Hohenzollern Clinic for Refractive
Surgery. LASIK stands for laser in situ keratotomy and is
surgery that corrects near-sightedness by reshaping the
cornea with a laser
|
ROCHESTER, Minn. -- A Mayo
Clinic study comparing femtosecond (bladeless) and mechanical
microkeratome LASIK surgeries has found equal results from both
types six months post-surgery, using a variety of vision and eye
health measurements. The study's findings will be presented next
week in three abstracts at the Association for Research in Vision
and Ophthalmology meeting in Fort Lauderdale, Fla.
LASIK (Laser-assisted in situ
keratomileusis) involves treating nearsightedness, farsightedness
or astigmatism by reshaping the eye's cornea to alter the way the
eye refracts light. LASIK involves creating a flap, removing a
defined amount of corneal tissue by an excimer laser, and
replacing the flap. In standard LASIK with a mechanical
microkeratome, the flap is created by a blade; in bladeless
LASIK, the newer type, the flap is created by a femtosecond
laser.
"At six months after
surgery, there are no differences between the eyes that had
bladeless or microkeratome LASIK with respect to visual acuity
(vision as measured by reading an eye chart), contrast
sensitivity (ability to discriminate bright objects from dark
objects), or in perception of stray light or glare, such as the
glare from oncoming headlights," says Sanjay Patel, M.D.,
Mayo Clinic ophthalmologist and study investigator.
Given the equivalent findings
thus far in eye health and vision between the two types of LASIK,
Dr. Patel slightly prefers bladeless LASIK due to its potential
safety, which was not measured in his study. "I'd say the
short-term outcomes are equal and the risks are, in theory, less
with the bladeless technique, although our study was not designed
to compare risks," he says. "Bladeless LASIK is
potentially safer because of its computer-controlled precision,
the ability to visualize the flap being created, and to stop the
procedure whenever necessary. That said, however, the risk of
complications with a traditional, microkeratome blade is very
small: some vision loss from surgery with a microkeratome blade
occurs in well under 1 percent of all cases. The long-term risks
of either procedure, however, are unknown, and defining them is
the primary purpose of our study."
The study followed 20 patients
who received LASIK for nearsightedness or astigmatism. Each
patient was treated with microkeratome LASIK in one eye and
bladeless LASIK in the other eye. The researchers found no
difference in subbasal nerve density between types of surgery,
though the density decreased after both treatments compared to
density before LASIK. Corneal sensitivity did not differ between
microkeratome and bladeless LASIK. Subbasal nerve density and
corneal sensitivity do not impact vision, but rather the
potential to heal from a scratch or other injury to the eye.
High-contrast visual acuity, the capability to see fine details,
and contrast sensitivity, the ability to perceive contrast in
objects and their environments, also did not differ between LASIK
types. The researchers found corneal backscatter was greater with
bladeless LASIK for the first three months after surgery, yet the
patients perceived no difference in vision after three months
between their eyes treated with bladeless or microkeratome LASIK.
Backscatter is haziness in the cornea that is usually invisible
to the naked eye and is identified through testing in a
physician's office. Cell densities in all layers of the cornea
also did not differ between the LASIK surgeries.
The ultimate goal of the Mayo
Clinic study of microkeratome versus bladeless LASIK is to obtain
long-term information about patients' vision and eye health five
years following surgery. The results presented now represent the
first six months of findings.
Other Mayo Clinic researchers
involved in this study include: Cherie Nau; Jay McLaren, Ph.D.;
Jay C. Erie, M.D.; Leo Maguire, M.D.; and William Bourne, M.D.
None of the investigators has any commercial interests. The study
was funded by the National Institutes of Health, Research to
Prevent Blindness, and Mayo Clinic.
Source
/ Credit: Mayo Clinic
|
|